Earnings release
Page 1
EX - 99.1 2 d177598dex991.htm EX - 99.1 amedisys Exhibit 99.1 AMEDISYS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS UPDATES 2021 GUIDANCE BATON ROUGE , Louisiana ( April 28 , 2021 ) - Amedisys , Inc. ( NASDAQ : AMED ) today reported its financial results for the three - month period ended March 31 , 2021 . Three - Month Periods Ended March 31 , 2021 and 2020 • Net service revenue increased $ 45.4 million to $ 537.1 million compared to $ 491.7 million in 2020 . Net income attributable to Amedisys , Inc. of $ 49.9 million compared to $ 31.8 million in 2020 . Net income attributable to Amedisys , Inc. per diluted share of $ 1.50 compared to $ 0.96 in 2020 . Adjusted Quarterly Results * * Adjusted EBITDA of $ 78.6 million compared to $ 53.3 million in 2020 . Adjusted net income attributable to Amedisys , Inc. of $ 51.1 million compared to $ 34.8 million in 2020 . Adjusted net income attributable to Amedisys , Inc. per diluted share of $ 1.54 compared to $ 1.05 in 2020 . See pages 11 and 12 for the definition and reconciliations of non - GAAP financial measures to GAAP measures . Paul B. Kusserow , Chairman and Chief Executive Officer stated , “ I am proud of our first quarter results and our continued performance in our four strategic pillars . Home Health has carried its strong momentum exiting 2020 into the first quarter of 2021 , and though Hospice continues to see the impact of COVID - 19 on average daily census , we are performing ahead of our projections and expect to continue to make good progress throughout 2021. We are also innovating close - to - the - core , growing inorganically , generating a prodigious amount of cash flow and remain in a position of very low leverage . We are excited about the growth opportunity both organically and inorganically this year and beyond and expect to be at the forefront of industry consolidation . Our industry leading quality , innovations mindset and payor orientation have materially differentiated Amedisys and have helped us take incremental steps towards being the leading aging - in - place , chronic care management company . A special thank you to all of our clinical staff and teams whose unwavering dedication to providing best - in - class clinical care has once again translated into strong financial results . ” 1